2004
DOI: 10.1002/art.20379
|View full text |Cite
|
Sign up to set email alerts
|

In vivo imaging of protease activity in arthritis: A novel approach for monitoring treatment response

Abstract: Objective. Sensitive noninvasive strategies for monitoring treatment response in rheumatoid arthritis (RA) would be valuable for facilitating appropriate therapy and dosing, evaluating clinical outcome, and developing more effective drugs. Because different proteases are highly up-regulated in RA and contribute significantly to joint destruction, in the present study we investigated whether such enzymes are suitable in vivo imaging biomarkers for early evaluation of treatment response in a murine model of RA.M… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
111
0

Year Published

2006
2006
2012
2012

Publication Types

Select...
3
3
3

Relationship

4
5

Authors

Journals

citations
Cited by 156 publications
(112 citation statements)
references
References 29 publications
1
111
0
Order By: Relevance
“…The reduction of protease-activated fluorescence signal in response to methotrexate treatment has been observed in the murine collagen-induced arthritis model (16). However, that study did not include analysis of the correlation between the decrease in protease-activated fluorescence signal and clinical disease indices such as redness, swelling, and ankylosis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The reduction of protease-activated fluorescence signal in response to methotrexate treatment has been observed in the murine collagen-induced arthritis model (16). However, that study did not include analysis of the correlation between the decrease in protease-activated fluorescence signal and clinical disease indices such as redness, swelling, and ankylosis.…”
Section: Discussionmentioning
confidence: 99%
“…Since we detected increased mRNA levels for cathepsins B and K in arthritic joints, which were inhibited in the ML120B-treated group, we selected an optical probe activated by cathepsin proteases to monitor protease activity in vivo. The Prosense "smart" probe is an enzyme-cleavable fluorescent probe specific for a defined subset of proteases, including cathepsins B and K. Probe fluorescence remains quenched when the probe is administered intravenously, until activation by enzyme cleavage in the target tissue (16). The Prosense probe was injected into control, vehicle-treated, and 60 mg/kg ML120B-treated animals, and an in vivo image was captured and fluorescence intensity in paws quantified ( Figure 5A).…”
Section: Response To Ikk-2 Inhibition In Arthritic Micementioning
confidence: 99%
“…These allow examination of protease-activated near-infrared fluorescence, enabling noninvasive acquisition, on a molecular level, of quantitative information about the presence and anatomic location of transgene expression (25) and target enzymes in arthritis research (26).…”
Section: Discussionmentioning
confidence: 99%
“…In particular, tomographic fluorescence imaging of near-infraredlabeled imaging agents has the potential to be used in drug discovery RAS research by virtue of improved deep tissue penetration, quantitative readout (picomoles rather than relative light intensity), and the pairing with protease-activated NIR imaging agents. This approach has been shown to be effective for the assessment and monitoring of protease activity associated with various diseases, including cancer (20), atherosclerosis (4), lung inflammation, and arthritis (26,33). In a similar fashion, noninvasive imaging and quantification of renin activity in vivo and monitoring of response to therapeutics could have a significant impact on the development of cardiovascular disease-targeted drugs in both preclinical and clinical settings.…”
mentioning
confidence: 99%